BML-210

HDAC inhibitor



BML-GR330-0001	1 mg	73.00 USD

BML-GR330-0005	5 mg	243.00 USD

HDAC inhibitor developed at Enzo Life Sciences. Inhibits HDAC activity in HeLa nuclear extracts (IC₅₀=5-10µM).

Product Specification

Formula:	C₂₀H₂₅N₃O₂

Purity:	≥98% (TLC)

Appearance:	Tan solid

CAS:	537034-17-6

Solubility:	Soluble in DMSO (25mg/ml) or 100% ethanol (10mg/ml, warm)

Long Term Storage:	-20°C

Background / Technical Information:	Please click here for the comprehensive product datasheet.

Please mouse over

Product Literature References

Herman et al.; Nature Chem. Biol. 10, 551 (2006),

The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines: J. Savickiene et al.; Eur J Pharmacol 549, 9 (2006), Abstract;